rdf:type |
|
lifeskim:mentions |
umls-concept:C0013072,
umls-concept:C0024554,
umls-concept:C0205314,
umls-concept:C0593802,
umls-concept:C0673074,
umls-concept:C0679622,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-7-1
|
pubmed:abstractText |
Novel aromatase inhibitors are developed with requirements of high potency and selectivity for the aromatase enzyme. The hormonal effects of a new, non-steroidal competitive inhibitor of the aromatase enzyme, MPV-2213ad, were investigated in this study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0031-6970
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
27-34
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10206081-Adult,
pubmed-meshheading:10206081-Aromatase Inhibitors,
pubmed-meshheading:10206081-Binding, Competitive,
pubmed-meshheading:10206081-Circadian Rhythm,
pubmed-meshheading:10206081-Double-Blind Method,
pubmed-meshheading:10206081-Electrocardiography,
pubmed-meshheading:10206081-Enzyme Inhibitors,
pubmed-meshheading:10206081-Hemodynamics,
pubmed-meshheading:10206081-Hormones,
pubmed-meshheading:10206081-Humans,
pubmed-meshheading:10206081-Male,
pubmed-meshheading:10206081-Microscopy, Electron, Scanning,
pubmed-meshheading:10206081-Nitriles,
pubmed-meshheading:10206081-Placebos,
pubmed-meshheading:10206081-Triazoles,
pubmed-meshheading:10206081-Urinalysis
|
pubmed:year |
1999
|
pubmed:articleTitle |
A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjects.
|
pubmed:affiliation |
Department of Pharmacology and Clinical Pharmacology, University of Turku, Turku University Central Hospital, Finland. outi.ahokoski@utu.fi
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|